Omega Healthcare Investors, Inc. (FRA:WX4)
Germany · Delayed Price · Currency is EUR 36.08
+0.28 (0.78%)
At close: Jan 28, 2026
FRA:WX4 Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Rental Revenue | 971.11 | 887.91 | 826.39 | 751.23 | 923.68 | 753.43 |
Other Revenue | 4.78 | 6.27 | 3.46 | 3.09 | 1.72 | 3.64 |
| 1,150 | 1,051 | 949.74 | 878.24 | 1,063 | 892.38 | |
Revenue Growth (YoY | 13.73% | 10.70% | 8.14% | -17.37% | 19.10% | -3.92% |
Property Expenses | 13.51 | 14.56 | 15.03 | 15.5 | 12.26 | 12.32 |
Selling, General & Administrative | 102.24 | 88 | 81.5 | 69.4 | 64.63 | 59.89 |
Depreciation & Amortization | 321.11 | 304.65 | 319.68 | 332.41 | 342.01 | 329.92 |
Provision for Loan Losses | 4.31 | 15.48 | -44.56 | -68.66 | -77.02 | -34.92 |
Total Operating Expenses | 432.55 | 391.73 | 460.77 | 485.97 | 495.92 | 437.05 |
Operating Income | 717.65 | 659.66 | 488.97 | 392.28 | 566.89 | 455.33 |
Interest Expense | -218.53 | -221.72 | -235.53 | -233.24 | -234.6 | -223.39 |
Income (Loss) on Equity Investments | -2.22 | 7.92 | -0.58 | 7.26 | 16.06 | 6.14 |
Other Non-Operating Income | 32.86 | 6.83 | 20.3 | -2 | -0.58 | -0.88 |
EBT Excluding Unusual Items | 529.76 | 452.69 | 273.16 | 164.3 | 347.77 | 237.21 |
Merger & Restructuring Charges | -4.86 | -11.62 | -5.34 | -42.01 | -1.81 | -2.02 |
Gain (Loss) on Sale of Assets | 63.12 | 13.17 | 79.67 | 359.95 | 161.61 | 19.11 |
Total Insurance Settlements | - | - | - | - | - | 3.5 |
Asset Writedown | -18.33 | -23.83 | -91.94 | -38.45 | -44.66 | -75.99 |
Other Unusual Items | -0.12 | -1.75 | -0.49 | -0.39 | -30.76 | -13.34 |
Pretax Income | 569.56 | 428.66 | 255.05 | 443.4 | 432.14 | 168.47 |
Income Tax Expense | 15.6 | 10.86 | 6.26 | 4.56 | 3.84 | 4.93 |
Earnings From Continuing Operations | 553.96 | 417.8 | 248.8 | 438.84 | 428.3 | 163.55 |
Minority Interest in Earnings | -15.27 | -11.48 | -6.62 | -11.91 | -11.56 | -4.22 |
Net Income | 538.69 | 406.33 | 242.18 | 426.93 | 416.74 | 159.33 |
Net Income to Common | 521.56 | 406.33 | 242.18 | 426.93 | 416.74 | 159.33 |
Net Income Growth | 54.80% | 67.78% | -43.27% | 2.44% | 161.56% | -53.29% |
Basic Shares Outstanding | 286 | 258 | 240 | 236 | 237 | 228 |
Diluted Shares Outstanding | 298 | 270 | 250 | 244 | 244 | 235 |
Shares Change (YoY) | 13.61% | 7.99% | 2.52% | -0.02% | 3.93% | 5.84% |
EPS (Basic) | 1.82 | 1.57 | 1.01 | 1.81 | 1.76 | 0.70 |
EPS (Diluted) | 1.80 | 1.55 | 1.00 | 1.80 | 1.75 | 0.70 |
EPS Growth | 31.87% | 55.44% | -44.60% | 2.48% | 151.99% | -56.10% |
Dividend Per Share | 2.680 | 2.680 | 2.680 | 2.680 | 2.680 | 2.680 |
Dividend Growth | - | - | - | - | - | 0.75% |
Operating Margin | 62.39% | 62.74% | 51.48% | 44.67% | 53.34% | 51.02% |
Profit Margin | 45.34% | 38.65% | 25.50% | 48.61% | 39.21% | 17.85% |
EBITDA | 1,037 | 962.63 | 799.21 | 719.02 | 899.39 | 771.07 |
EBITDA Margin | 90.16% | 91.56% | 84.15% | 81.87% | 84.62% | 86.41% |
D&A For Ebitda | 319.42 | 302.96 | 310.23 | 326.75 | 332.5 | 315.74 |
EBIT | 717.65 | 659.66 | 488.97 | 392.28 | 566.89 | 455.33 |
EBIT Margin | 62.39% | 62.74% | 51.48% | 44.67% | 53.34% | 51.02% |
Funds From Operations (FFO) | 834.66 | 733.91 | 591.18 | 460.54 | 655.24 | 555.94 |
FFO Per Share | 2.80 | 2.71 | 2.36 | - | - | - |
Adjusted Funds From Operations (AFFO) | - | 778.14 | 698.67 | 460.54 | 655.24 | 555.94 |
AFFO Per Share | - | 2.87 | 2.79 | - | - | - |
FFO Payout Ratio | 91.47% | 93.40% | 108.91% | 137.43% | 97.31% | 110.14% |
Effective Tax Rate | 2.74% | 2.53% | 2.45% | 1.03% | 0.89% | 2.92% |
Revenue as Reported | 1,150 | 1,051 | 949.74 | 878.24 | 1,063 | 892.38 |
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.